Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
The project will enhance Aspect Biosystems’ clinical development capabilities an...
As AI reshapes pharma, HR leadership is being drawn into a deeper question that...
The approval in the European Union (EU) is for adults with platinum-resistant ep...
Beyond the semaglutide momentum, a larger wave of patent expiries is set to unf...
Weight management drug to be available from Rs 3,999 per month from April 3, 20...
Bharat Bhardwaj, Vice President, Asia Pacific, Agilent Technologies spoke to Vi...
Agilent Technologies has announced the opening of its Customer Experience Cente...
RYALTRIS is Glenmark’s first innovative product introduced into the US market T...
The integration of VISUfarma has expanded Lupin’s ophthalmology portfolio to ov...
This follows the company’s signing of a definitive agreement in October 2025 to ...
Under the agreement, Biocytogen’s fully human antibody discovery platform will b...
The IND includes results from completed toxicology, pharmacology, and manufactur...
The partnership aims to explore a new class of small molecules, called molecular...
Platform to support compliance, training and documentation for over 9,000 lear...
India's Foremost Pharma & Biotech Magazine ~ Patent Expiries Ahead: Is India Ph...
As pharma companies deal with price wars, increasing regulatory heat and a vola...